Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114936) titled 'Application of 18F-FDG PET/CT Multimodal Metabolic Parameters in Invasive Lung Adenocarcinoma: A Diagnostic Test with a Cross-Sectional Study Design' on Dec. 19, 2025.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Peking University Shenzhen Hospital
Condition:
Patients diagnosed with lung adenocarcinoma
Intervention:
Gold Standard:All patients underwent thoracoscopic or open thoracotomy surgery within two weeks of the examination at our hospital to obtain pathological results. Two senior pathologists examined the specimens under a microscope and reached a consensus...